Mohamed Abdel-Wahab

Showing 1-20 of 27 articles

Coronary interventions

Super High-Pressure Balloon versus Scoring Balloon to Prepare Severely Calcified Coronary Lesions: The ISAR-CALC Randomized Trial

Rheude T, Rai H, Richardt G, Allali A, Abdel-Wahab M, Sulimov D, Mashayekhi K, Ayoub M, Cuculi F, Bossard M, Kufner S, Xhepa E, Kastrati A, Fusaro M, Joner M, Byrne R, Cassese S

December 4, 2020 | 10.4244/EIJ-D-20-01000

Bioresorbable vascular scaffold versus metallic drug-eluting stent in patients at high risk of restenosis: the COMPARE-ABSORB randomised clinical trial

Smits P, Chang C, Chevalier B, West N, Gori T, Barbato E, Tarantini G, Kocka V, Achenbach S, Dudek D, Escaned J, Wlodarczak A, Abdel-Wahab M, Esposito G, Tijssen J, Morice M, Onuma Y, van Geuns R

October 23, 2020 | 10.4244/EIJ-D-19-01079

Systematic use of intentional leaflet laceration to prevent TAVI-induced coronary obstruction: feasibility and early clinical outcomes of the BASILICA technique

Kitamura M, Majunke N, Holzhey D, Desch S, Bani Hani A, Krieghoff C, Gutberlet M, Protsyk V, Ender J, Borger M, Dvir D, Thiele H, Abdel-Wahab M

October 23, 2020 | 10.4244/EIJ-D-20-00386

Quantitative aortography assessment of aortic regurgitation

Modolo R, Chang C, Onuma Y, Schultz C, Tateishi H, Abdelghani M, Miyazaki Y, Aben J, Rutten M, Pighi M, El Bouziani A, van Mourik M, Lemos P, Wykrzykowska J, Brito F, Sahyoun C, Piazza N, Eltchaninoff H, Soliman O, Abdel-Wahab M, Van Mieghem N, de Winter R, Serruys P

October 9, 2020 | 10.4244/EIJ-D-19-00879

Outcomes of rotational atherectomy versus modified balloon angioplasty in severely calcified coronary lesions based on target lesion location: a post hoc analysis of the PREPARE-CALC randomised trial

Rheude T, Toelg R, Byrne R, Allali A, Wiebe J, Sulimov D, Voll F, Cassese S, Richardt G, Kastrati A, Abdel-Wahab M

July 17, 2020 | 10.4244/EIJ-D-19-00488

Fractional flow reserve-guided multivessel angioplasty in myocardial infarction: three-year follow-up with cost benefit analysis of the Compare-Acute trial

Smits P, Laforgia P, Abdel-Wahab M, Neumann F, Richardt G, Boxma-de Klerk B, Lunde K, Schotborgh C, Piroth Z, Horak D, Wlodarczak A, Frederix G, Omerovic E

June 25, 2020 | 10.4244/EIJ-D-20-00012

Long-term follow-up of patients with contained annulus ruptures after TAVI: the EuropeaN COntained RupturE (ENCORE) registry

Breitbart P, Minners J, Pache G, Hansson N, Nørgaard B, De Backer O, Søndergaard L, Alsanjari O, Hildick-Smith D, Abdel-Wahab M, Löbig S, Neumann F, Ruile P

May 20, 2020 | 10.4244/EIJ-D-19-00740

TAVI and horizontal aorta: a "no impact" relationship?

Abdel-Wahab M, Kitamura M, Thiele H

October 4, 2019 | 10.4244/EIJV15I9A136

Quantitative aortography for assessing aortic regurgitation after transcatheter aortic valve implantation: results of the multicentre ASSESS-REGURGE Registry

Modolo R, Chang C, Tateishi H, Miyazaki Y, Pighi M, Abdelghani M, Roos M, Wolff Q, Wykrzykowska J, de Winter R, Piazza N, Richardt G, Abdel-Wahab M, Soliman O, Onuma Y, Van Mieghem N, Serruys P

August 29, 2019 | 10.4244/EIJ-D-19-00362

TAVI and valve performance: update on definitions, durability, transcatheter heart valve failure modes and management

Eltchaninoff H, Durand E, Barbanti M, Abdel-Wahab M

September 7, 2018 | 10.4244/EIJ-D-18-00653

Interventions for valvular disease

Computed tomography-based oversizing and incidence of paravalvular aortic regurgitation and permanent pacemaker implantation with a new-generation self-expanding transcatheter heart valve

Kim U, Blanke P, Windecker S, Kasel A, Schäfer U, Walters D, Linke A, Le Breton H, Schymik G, Spence M, Søndergaard L, Abdel-Wahab M, Worthley S, Tchétché D, Reichenspurner H, Ohana M, Sellers S, Leipsic J

August 3, 2018 | 10.4244/EIJ-D-17-01040

Interventions for valvular disease

Long-term durability and haemodynamic performance of a self-expanding transcatheter heart valve beyond five years after implantation: a prospective observational study applying the standardised definitions of structural deterioration and valve failure

Holy E, Kebernik J, Abdelghani M, Stampfli SF, Hellermann J, Allali A, El-Mawardy M, Sachse S, Lüscher T, Tanner F, Richardt G, Abdel-Wahab M

July 20, 2018 | 10.4244/EIJ-D-18-00041

Interventions for valvular disease

Transcatheter aortic valve implantation with the 34 mm self-expanding CoreValve Evolut R: initial experience in 101 patients from a multicentre registry

Kuhn C, Frerker C, Meyer A-K, Kurz T, Schäfer U, Deuschl F, Abdel-Wahab M, Schewel D, Elghalban A, Kuck K, Frey N, Frank D

June 14, 2018 | 10.4244/EIJ-D-17-01153

Interventions for valvular disease

Impact of femoral artery puncture using digital subtraction angiography and road mapping on vascular and bleeding complications after transfemoral transcatheter aortic valve implantation

El-Mawardy M, Schwarz B, Landt M, Sulimov D, Kebernik J, Allali A, Becker B, Toelg R, Richardt G, Abdel-Wahab M

January 20, 2017 | 10.4244/EIJ-D-15-00412

Interventions for valvular disease

One-year outcomes with two suture-mediated closure devices to achieve access-site haemostasis following transfemoral transcatheter aortic valve implantation

Mehilli J, Jochheim D, Abdel-Wahab M, Rizas K, Theiss H, Spenkuch N, Zadrozny M, Baquet M, El-Mawardy M, Sato T, Lange P, Kupatt C, Greif M, Hausleiter J, Bauer A, Schwarz F, Pichlmaier M, Hagl C, Richardt G, Massberg S

November 20, 2016 | 10.4244/EIJV12I10A213

Interventions for valvular disease

Redo TAVI: initial experience at two German centres

Schmidt T, Frerker C, Alessandrini H, Schlüter M, Kreidel F, Schäfer U, Thielsen T, Kuck K, Jose J, Holy E, El-Mawardy M, Allali A, Richardt G, Abdel-Wahab M

September 18, 2016 | 10.4244/EIJV12I7A144

Coronary interventions

Incidence and predictors of unplanned non-target lesion revascularisation up to three years after drug-eluting stent implantation: insights from a pooled analysis of the RESOLUTE Global Clinical Trial Program

Abdel-Wahab M, Neumann F, Serruys P, Silber S, Leon M, Mauri L, Yeung A, Belardi J, Widimsky P, Meredith I, Saito S, Richardt G

July 20, 2016 | 10.4244/EIJY15M07_07

Coronary interventions

Hybrid strategy with a bioresorbable scaffold and a drug-coated balloon for diffuse coronary artery disease: the “no more metallic cages” multicentre pilot experience

Ielasi A, Miyazaki T, Geraci S, Testa L, Abdel-Wahab M, Kawamoto H, Ruparelia N, Sato T, Caramanno G, Bedogni F, Tespili M, Colombo A, Latib A

April 8, 2016 | 10.4244/EIJV11I14A309

Interventions for valvular disease

Transfemoral TAVI devices: design overview and clinical outcomes

Abdel-Wahab M, Jose J, Richardt G

September 17, 2015 | 10.4244/EIJV11SWA33

Selection of TAVI prostheses: do we really have the CHOICE?

Abdel-Wahab M, Richardt G

September 27, 2014 | 10.4244/EIJV10SUA5

Latest news

NEW ISSUE

Ischaemia with non-obstructive coronary arteries, OCT vs IVUS guidance in PCI; the ILUMIEN III and ILUMIEN IV trials…

Elective Cardiac Invasive Procedures during the COVID-19 Outbreak

A. Chieffo et al.

January 8, 2021

Editorial

Moving (re-shaping) the mitral annulus

Georg Nickenig

January 20, 2021

Trials Book

SCOPE 2, BASKET-SMALL 2 3 years, ALPHEUS, COMPARE-ABSORB, DUBIUS

(Thanks to the support of Biotronik)

January 13, 2021

Editorial

Use of intravascular OCT or IVUS to guide stent implantation.

Evelyn Regar

January 20, 2021

JAA

Last Week's JAA's: TTVr with the TriClip/MitraClip G4 System and much more...